Benjamin Shaker - 28 Dec 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
28 Dec 2021
Transactions value $
-$499,890
Form type
4
Filing time
30 Dec 2021, 15:46:31
Previous filing
18 Nov 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Sale -$376K -14.1K -16.47% $26.72 71.3K 28 Dec 2021 Direct F1, F2, F3
transaction AGL Common Stock Sale -$124K -4.69K -6.57% $26.54 66.6K 29 Dec 2021 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.45 to $27.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Includes restricted stock units.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.18 to $26.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.